Back to results
US 2015/0031616 A1Published application
Use of relaxin to treat placental syndromes
AssigneeUniversity of Florida Research Foundation, Inc.
InventorKIRK P. CONRAD
Life of this patent
Estimating the term…
Abstract
The subject application relates to methods for treating a placental syndrome, wherein relaxin is administered during the late secretory/luteal (LS) phase of the menstrual cycle in women who have a propensity for developing the placental syndrome. In certain embodiments, administration of relaxin continues beyond the LS phase and into pregnancy.
Claims23
A method for treating a placental syndrome in a woman comprising the steps of:
- (a) determining whether a woman has experienced a placental syndrome during a previous pregnancy;
- (b) if the woman has experienced a placental syndrome during a previous pregnancy, determining the late secretory/luteal (LS) phase of the menstrual cycle;
- and (c) administering a therapeutically effective amount of relaxin to the woman during the LS phase of menstruation to treat the placental syndrome.
A method for treating a placental syndrome in a woman comprising the steps of:
- (a) diagnosing whether a woman will have a propensity for developing a placental syndrome;
- (b) if the woman is one who has a propensity for developing a placental syndrome, determining the late secretory/luteal (LS) phase of the menstrual cycle;
- and (c) administering a therapeutically effective amount of a relaxin to the woman during the LS phase of menstruation.
Dependencies are inferred from the claim text.